Clinical Trials Browser

Phase 2 × Digoxin × 1 year × Clear all

NCT04141995 2025-08-07

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT01162135 2025-05-04

Digoxin for Recurrent Prostate Cancer

Phase 2 Completed

16 enrolled 7 charts

Prostatic Neoplasms